Sign in
SXTPW Stock Price, Chart, Stats & News
60 Degrees Pharmaceuticals, Inc. Warrant
Save
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
SXTPW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 5.85% |
Operating margin | -831.98% |
Pretax margin | -844.26% |
Net margin | -844.41% |
Effective tax rate | -0.03% |
ROA | -88.63% |
ROE | -165.89% |
D/E | – |
Interest coverage ratio | -4482.91x |
SXTPW valuation
P/E | – |
P/S | – |
P/B | – |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | – |
EV multiple | – |
About
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue.
Similar securities
Based on sector and market capitalization
Report issue